159 related articles for article (PubMed ID: 24425003)
21. Inhibition of HBV replication and gene expression in vitro and in vivo with a single AAV vector delivering two shRNA molecules.
Li Z; He ML; Yao H; Dong QM; Chen YC; Chan CY; Zheng BJ; Yuen KY; Peng Y; Sun Q; Yang X; Lin MC; Sung JJ; Kung HF
BMB Rep; 2009 Jan; 42(1):59-64. PubMed ID: 19192395
[TBL] [Abstract][Full Text] [Related]
22. HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice.
Tsuge M; Hiraga N; Akiyama R; Tanaka S; Matsushita M; Mitsui F; Abe H; Kitamura S; Hatakeyama T; Kimura T; Miki D; Mori N; Imamura M; Takahashi S; Hayes CN; Chayama K
J Gen Virol; 2010 Jul; 91(Pt 7):1854-64. PubMed ID: 20219897
[TBL] [Abstract][Full Text] [Related]
23. [Establishment of hepatitis B virus (HBV) chronic infection mouse model by in vivo transduction with a recombinant adeno-associated virus 8 carrying 1. 3 copies of HBV genome (rAAN8-1. 3HBV)].
Dong XY; Yu CJ; Wang G; Tian WH; Lu Y; Zhang FW; Wang W; Wang Y; Tan WJ; Wu XB
Bing Du Xue Bao; 2010 Nov; 26(6):425-31. PubMed ID: 21344744
[TBL] [Abstract][Full Text] [Related]
24. Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs.
Carmona S; Ely A; Crowther C; Moolla N; Salazar FH; Marion PL; Ferry N; Weinberg MS; Arbuthnot P
Mol Ther; 2006 Feb; 13(2):411-21. PubMed ID: 16337206
[TBL] [Abstract][Full Text] [Related]
25. Lentiviral backbone-based hepatitis B virus replicon-mediated transfer favours the establishment of persistent hepatitis B virus infection in mice after hydrodynamic injection.
Chuai X; Wang W; Chen H; Deng Y; Wen B; Tan W
Antiviral Res; 2014 Jan; 101():68-74. PubMed ID: 24239872
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of hepatitis B virus by lentiviral vector delivered antisense RNA and hammerhead ribozymes.
Nash KL; Alexander GJ; Lever AM
J Viral Hepat; 2005 Jul; 12(4):346-56. PubMed ID: 15985004
[TBL] [Abstract][Full Text] [Related]
27. Granzyme H of cytotoxic lymphocytes is required for clearance of the hepatitis B virus through cleavage of the hepatitis B virus X protein.
Tang H; Li C; Wang L; Zhang H; Fan Z
J Immunol; 2012 Jan; 188(2):824-31. PubMed ID: 22156339
[TBL] [Abstract][Full Text] [Related]
28. Conditional expression of IFN-alpha and IFN-gamma activated by HBV as genetic therapy for hepatitis B.
Matskevich AA; Cordelier P; Strayer DS
J Interferon Cytokine Res; 2003 Dec; 23(12):709-21. PubMed ID: 14769147
[TBL] [Abstract][Full Text] [Related]
29. Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner.
Han Q; Zhang C; Zhang J; Tian Z
Hepatology; 2011 Oct; 54(4):1179-89. PubMed ID: 21721030
[TBL] [Abstract][Full Text] [Related]
30. Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector.
Byun J; Heard JM; Huh JE; Park SJ; Jung EA; Jeong JO; Gwon HC; Kim DK
J Mol Cell Cardiol; 2001 Feb; 33(2):295-305. PubMed ID: 11162134
[TBL] [Abstract][Full Text] [Related]
31. Repression of hepatitis B virus X gene expression by hammerhead ribozymes.
Kim YK; Junn E; Park I; Lee Y; Kang C; Ahn JK
Biochem Biophys Res Commun; 1999 Apr; 257(3):759-65. PubMed ID: 10208856
[TBL] [Abstract][Full Text] [Related]
32. IFN-alpha gene therapy for woodchuck hepatitis with adeno-associated virus: differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes.
Berraondo P; Ochoa L; Crettaz J; Rotellar F; Vales A; Martínez-Ansó E; Zaratiegui M; Ruiz J; González-Aseguinolaza G; Prieto J
Mol Ther; 2005 Jul; 12(1):68-76. PubMed ID: 15963922
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus enhances transduction of human hepatocytes by SV40-based vectors.
Arad U; Axelrod J; Ben-nun-Shaul O; Oppenheim A; Galun E
J Hepatol; 2004 Mar; 40(3):520-6. PubMed ID: 15123369
[TBL] [Abstract][Full Text] [Related]
34. Analysis of carriers of hepatitis B virus from a tertiary referral hospital: does the viral load change during the natural course of infection?
Aakanksha ; Asim M; Sharma PK; Das BC; Kar P
J Med Virol; 2011 Jul; 83(7):1151-8. PubMed ID: 21520137
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus inhibits liver regeneration via epigenetic regulation of urokinase-type plasminogen activator.
Park ES; Park YK; Shin CY; Park SH; Ahn SH; Kim DH; Lim KH; Kwon SY; Kim KP; Yang SI; Seong BL; Kim KH
Hepatology; 2013 Aug; 58(2):762-76. PubMed ID: 23483589
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death.
Leupin O; Bontron S; Schaeffer C; Strubin M
J Virol; 2005 Apr; 79(7):4238-45. PubMed ID: 15767425
[TBL] [Abstract][Full Text] [Related]
37. Efficient silencing of hepatitis B virus by helper-dependent adenovirus vector-mediated delivery of artificial antiviral primary micro RNAs.
Mowa MB; Crowther C; Ely A; Arbuthnot P
Microrna; 2012; 1(1):19-25. PubMed ID: 25048086
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of HBx mRNA in HepG2.2.15 cells by small interfering RNA.
Jiao J; Cao H; Chen XW; Zhou MJ; Liu ZH; Ding ZH
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1114-8. PubMed ID: 17998838
[TBL] [Abstract][Full Text] [Related]
39. Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection.
Untergasser A; Zedler U; Langenkamp A; Hösel M; Quasdorff M; Esser K; Dienes HP; Tappertzhofen B; Kolanus W; Protzer U
Hepatology; 2006 Mar; 43(3):539-47. PubMed ID: 16496321
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma.
Kim KH; Shin HJ; Kim K; Choi HM; Rhee SH; Moon HB; Kim HH; Yang US; Yu DY; Cheong J
Gastroenterology; 2007 May; 132(5):1955-67. PubMed ID: 17484888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
